Kosmix
One sec... we're building your guide for
Edrecolomab
Edrecolomab
Overview
Reference
News & Blogs
Main ›
Related in the Kosmos
?
Antineoplastic drugs
Catumaxomab
Sunitinib
Alemtuzumab
Lapatinib
Sorafenib
Bevacizumab
Monoclonal antibodies
(186)
3F8
Abagovomab
Afelimomab
Aflibercept
Altumomab
Altumomab
Anatumomab mafenatox
Arcitumomab
Bectumomab
Besilesomab
Detumomab
Edobacomab
Fanolesomab
Igovomab
Imciromab
Lemalesomab
Minretumomab
Mitumomab
Nacolomab tafenatox
Naptumomab estafenatox
Oregovomab
Pemtumomab
Pintumomab
Sulesomab
Taplitumomab paptox
Tenatumomab
Abatacept
Abciximab
Abzyme
Adalimumab
Adecatumumab
Afutuzumab
Alacizumab pegol
Alemtuzumab
Apolizumab
Aselizumab
Atorolimumab
Bapineuzumab
Basiliximab
Bavituximab
Belatacept
Belimumab
Bertilimumab
Bevacizumab
Biciromab
Bispecific monoclonal antibody
Bivatuzumab mertansine
Blinatumomab
Brentuximab vedotin
Cambridge Antibody Technology
Canakinumab
Cantuzumab mertansine
Catumaxomab
Cedelizumab
Certolizumab pegol
Cetuximab
Citatuzumab bogatox
Cixutumumab
Clenoliximab
Conatumumab
Dacetuzumab
Daclizumab
Denosumab
Dorlixizumab
Ecromeximab
Eculizumab
Efalizumab
Efungumab
Elotuzumab
Elsilimomab
Epratuzumab
Erlizumab
Ertumaxomab
Etanercept
Etaracizumab
Exbivirumab
Faralimomab
Farletuzumab
Felvizumab
Figitumumab
Fontolizumab
Foravirumab
Fresolimumab
Galiximab
Gantenerumab
Gavilimomab
Gemtuzumab ozogamicin
Golimumab
Gomiliximab
HuMax
Humanized antibody
Ibalizumab
Ibritumomab tiuxetan
Indium (111In) capromab pendetide
Indium (111In) satumomab pendetide
Infliximab
Inolimomab
Inotuzumab ozogamicin
Ipilimumab
Iratumumab
Keliximab
Labetuzumab
Lebrikizumab
Lerdelimumab
Lexatumumab
Libivirumab
Lintuzumab
List of monoclonal antibodies
Lucatumumab
Lumiliximab
Mapatumumab
Maslimomab
Matuzumab
Mepolizumab
Metelimumab
Milatuzumab
Morolimumab
Motavizumab
Natalizumab
Nebacumab
Necitumumab
Nerelimomab
Nimotuzumab
Nomenclature of monoclonal antibodies
Ocrelizumab
Odulimomab
Ofatumumab
Omalizumab
Oportuzumab monatox
Otelixizumab
PRO 140
Pagibaximab
Palivizumab
Panitumumab
Panobacumab
Pascolizumab
Personalized medicine
Pertuzumab
Pexelizumab
Priliximab
Pritumumab
Rafivirumab
Ramucirumab
Ranibizumab
Raxibacumab
Regavirumab
Reslizumab
Rilonacept
Rituximab
Robatumumab
Rovelizumab
Ruplizumab
Sevirumab
Sibrotuzumab
Siltuximab
Siplizumab
Solanezumab
Stamulumab
TGN1412
Tadocizumab
Talizumab
Tanezumab
Technetium (99mTc) nofetumomab merpentan
Technetium (99mTc) votumumab
Tefibazumab
Telimomab aritox
Teneliximab
Teplizumab
Tigatuzumab
Tocilizumab
Toralizumab
Trastuzumab
Tremelimumab
Tucotuzumab celmoleukin
Tuvirumab
Urtoxazumab
Ustekinumab
Vapaliximab
Vedolizumab
Veltuzumab
Vepalimomab
Visilizumab
Volociximab
Yttrium (90Y) tacatuzumab tetraxetan
Zalutumumab
Zanolimumab
Zolimomab aritox
more...
Cancer treatments
(135)
Bosutinib
Semaxanib
ABVD
Acoustic neuroma
Adjuvant chemotherapy
Adjuvant chemotherapy
Alternative cancer treatments
Altumomab
Anatumomab mafenatox
Anti-CD22 immunotoxins
Antineoplastic drugs
Artemisinin
BCG as a treatment for bladder cancer
BEACOPP
Bavituximab
Bectumomab
Biomed 101
Bivatuzumab mertansine
Blinatumomab
CA15-3
CBV (chemotherapy)
CDEPT
CHOP
COPP
Cancer immunotherapy
Cancer vaccine
Cantuzumab mertansine
Cell transfer therapy
Cervical conization
Chemoembolization
Chemoimmunotherapy
Chemotherapy
Cilengitide
Cyberknife
Cytoluminescent therapy
DVS: Dose verification system
Dacetuzumab
Detumomab
Donor lymphocyte infusion
Dose-dense chemotherapy
Electrochemotherapy
Elotuzumab
Epratuzumab
Ertumaxomab
Esophageal stent
Etaracizumab
Experimental cancer treatment
FOLFIRI
FOLFOX
Figitumumab
Gamma knife
Gavilimomab
Gefitinib
Hazardous drugs
HyperCVAD
Hyperthermia therapy
ICE chemotherapy regimen
IFL chemotherapy
Ibritumomab tiuxetan
Igovomab
Image-guided radiation therapy
Immunoconjugate
Immunotherapy
Indolocarbazole
Inotuzumab ozogamicin
Insulin potentiation therapy
Intraoperative Electron Radiation Therapy
Intraperitoneal hyperthermic chemoperfusion
Ipilimumab
Iratumumab
Isolated limb perfusion
Krebiozen
Labetuzumab
Lexatumumab
Lintuzumab
Loop electrical excision procedure
Lorraine Day
Low-dose chemotherapy
Lucatumumab
MagForce Nanotechnologies
Magnetic hyperthermia
Management of prostate cancer
Mapatumumab
Matuzumab
Mertansine
Metastasectomy
Minretumomab
Mitotic inhibitor
Mitumomab
Monoclonal antibody therapy
Nacolomab tafenatox
Naptumomab estafenatox
Nimotuzumab
Ofatumumab
Olaparib
Oncophage
Oregovomab
Panobinostat
Particle therapy
Pemtumomab
Percutaneous hepatic perfusion
Photodynamic therapy
Photothermal Therapy
Pintumomab
Pritumumab
ProCure Treatment Centers
Proton therapy
Provascular anticancer therapy
Radiation burn
Radiation oncology
Radiation therapy
Radiofrequency ablation
Radioimmunotherapy
Radiosurgery
Retroperitoneal lymph node dissection
Romidepsin
Rubitecan
SN-38
Selective internal radiation therapy
Sibrotuzumab
Sonodynamic therapy
Stereotactic surgery
TH-302
Tamoxifen
Taplitumomab paptox
Targeted therapy
Tirapazamine
TroVax
Tronado Machine
Tucotuzumab celmoleukin
Tyrosine kinase inhibitors
Unsealed source radiotherapy
Volociximab
Wedge resection
Yttrium (90Y) tacatuzumab tetraxetan
Zalutumumab
more...
Technetium compounds
(9)
Bectumomab
Besilesomab
Fanolesomab
Pertechnetates
Pintumomab
Pintumomab
Technetium (99mTc) nofetumomab merpentan
Technetium(IV) chloride
Technetium(VI) fluoride
Technetium(VII) oxide
more...
Radiopharmaceuticals
(14)
2-Deoxy-D-glucose
90Y-DOTA-biotin
Arcitumomab
Exametazime
Fludeoxyglucose
Fludeoxyglucose
Imciromab
Indium (111In) capromab pendetide
Indium (111In) satumomab pendetide
Iobenguane
McN5652
Samarium (153Sm) lexidronam
Sulesomab
Technetium (99mTc) tetrofosmin
Technetium (99mTc) votumumab
more...
Tyrosine kinase receptors
(22)
ErbB
HER1
HER2/neu
RTK class III
Angiopoietin receptor
Angiopoietin receptor
ERBB3
Fibroblast growth factor receptor
Fibroblast growth factor receptor 2
Fibroblast growth factor receptor 3
Insulin receptor
Insulin-like growth factor 1 receptor
Kinase insert domain receptor
MuSK protein
RET proto-oncogene
Receptor tyrosine kinase
TIE1
Tir (receptor)
Trk receptor
TrkA
TrkB
TrkC
VEGF receptors
more...
Tyrosine kinase inhibitors
(15)
Axitinib
Lestaurtinib
Vandetanib
Bosutinib
Cediranib
Cediranib
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Semaxanib
Sunitinib
Toceranib
Vatalanib
more...
ATC codes
ATC code V09
ATC code V10
ATC code L01
Anatomical Therapeutic Chemical Classification System
See also
(11)
Drugs
Biciromab brallobarbital
Chemotherapeutic agents
Bcr-abl fusion protein
EpCAM
EpCAM
Antigen
Chemical substances
Antineoplastic
Renal function
Extracellular
Mouse
more...
more categories...
